Nimorazole USP from China
Nimorazole is a 5-nitroimidazole derivative used in radiosensitization therapy with an unfused imidazole ring. Classified as aromatic heterocyclic under HTS 2933.29.43.00.
Duty Rate — China → United States
137.5%
Rate breakdown
9903.04.6093.5%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.3112.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of China, as provided for in U.S. note 52 to this subchapter
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
Import Tips
• Provide radiation stability data for therapeutic applications,Include USP monograph compliance testing results,Declare research/therapeutic use to avoid controlled substance scrutiny